Zoladex® 10.8 BC RWS

Trial Identifier:	D8664R00002
Sponsor:	AstraZeneca
NCTID::	NCT05184257
Start Date:	January 2022
Primary Completion Date:	December 2023
Study Completion Date:	December 2023
Condition:	Breast Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
China	Beijing, China, 100021
China	Changsha, China, 410013
China	Chengdu, China
China	Guangan, China
China	Guangyuan, China
China	Guangzhou, China, 510060
China	Guangzhou, China
China	Hangzhou, China
China	Jinan, China, 250117
China	Nantong, China
China	Shanghai, China, 200032
China	Suzhou, China, 215006
China	Suzhou, China
China	Taiyuan, China
China	Tianjin, China, 300060
China	Xining, China

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company